Literature DB >> 1892099

Usefulness of corticosteroid therapy for protein-losing enteropathy after the Fontan procedure.

J Rychik1, D A Piccoli, G Barber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1892099     DOI： 10.1016/0002-9149(91)90667-a

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  13 in total

1.  Protein-losing enteropathy after fontan operation: treatment with elementary diet in one case.

Authors:  G Guariso; A Cerutti; G S Moreolo; O Milanesi
Journal:  Pediatr Cardiol       Date:  2000 May-Jun       Impact factor: 1.655

2.  Protein-losing enteropathy after the modified fontan operation: oral prednisone treatment with biopsy and laboratory proved improvement.

Authors:  T M Zellers; K Brown
Journal:  Pediatr Cardiol       Date:  1996 Mar-Apr       Impact factor: 1.655

3.  Regression of post-Fontan protein-losing enteropathy. After surgical correction of hemodynamic faults other than high right atrial pressure.

Authors:  F Ventriglia; L Mundo; G Bosco; V Colloridi
Journal:  Tex Heart Inst J       Date:  1996

4.  Evidence of Systemic Absorption of Enteral Budesonide in Patients with Fontan-Associated Protein-Losing Enteropathy.

Authors:  Richard Ogden Roberts; Michael V Di Maria; Dania Brigham; Stephanie Hsu
Journal:  Pediatr Cardiol       Date:  2019-11-09       Impact factor: 1.655

5.  Comparison of Immune Profiles in Fetal Hearts with Idiopathic Dilated Cardiomyopathy, Maternal Autoimmune-Associated Dilated Cardiomyopathy and the Normal Fetus.

Authors:  Lynne E Nield; Ingo von Both; Najla Popel; Kate Strachan; Cedric Manlhiot; Patrick Shannon; Brian W McCrindle; Adelle Atkinson; Steven E S Miner; Edgar T Jaeggi; Glenn P Taylor
Journal:  Pediatr Cardiol       Date:  2015-10-20       Impact factor: 1.655

6.  Significance of circulating hepatocyte growth factor in protein-losing enteropathy after Fontan operation.

Authors:  Gi Beom Kim; Bo Sang Kwon; Eun Jung Bae; Chung Il Noh; Jung Yun Choi
Journal:  Pediatr Cardiol       Date:  2011-06-11       Impact factor: 1.655

7.  Oral budesonide treatment for protein-losing enteropathy in Fontan-palliated patients.

Authors:  Kurt R Schumacher; Michael Cools; Bryan H Goldstein; Viktoriya Ioffe-Dahan; Karen King; Diane Gaffney; Mark W Russell
Journal:  Pediatr Cardiol       Date:  2011-06-10       Impact factor: 1.655

8.  Prevalence of Subclinical Enteric Alpha-1-Antitrypsin Loss in Children with Univentricular Circulation Following Total Cavopulmonary Connection.

Authors:  Colm R Breatnach; Aoife Cleary; Terence Prendiville; Kathleen Crumlish; Helene Murchan; Colin J McMahon
Journal:  Pediatr Cardiol       Date:  2017-09-06       Impact factor: 1.655

9.  The Use of Fecal Calprotectin Levels in the Fontan population.

Authors:  Carlos Miranda; Anas Taqatqa; Adrian Chapa-Rodriguez; Jacob P Holton; Sawsan M Awad
Journal:  Pediatr Cardiol       Date:  2017-12-28       Impact factor: 1.655

10.  The Fontan pathway: What's down the road?

Authors:  Sachin Khambadkone
Journal:  Ann Pediatr Cardiol       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.